Avro Lifesci

Avro Life Science is a leading preclinical stage pharmaceutical company developing patches for transdermal drug delivery, providing a platform technology for the passive delivery of small molecules. Avro's novel polymer utilizes cutting-edge advances in biomaterials engineering and micro-encapsulation technology to hold and deliver a wide range of drugs over a 1-7-day timespan, where transdermal delivery was previously thought to be impossible. The Company is currently establishing co-development and licensing agreements with leading pharmaceutical companies prior to launching their own clinical programs in 2021.